Carboxy-terminal truncations of epidermal growth factor (EGF) receptor affect diverse EGF-induced cellular responses
- PMID: 1777506
- PMCID: PMC361854
- DOI: 10.1091/mbc.2.8.641
Carboxy-terminal truncations of epidermal growth factor (EGF) receptor affect diverse EGF-induced cellular responses
Abstract
The binding of epidermal growth factor (EGF) to its receptor induces tyrosine phosphorylation of phospholipase C gamma (PLC gamma), which appears to be necessary for its activation leading to phosphatidyl inositol (PI) hydrolysis. Moreover, EGF-receptor (EGF-R) activation and autophosphorylation results in binding of PLC gamma to the tyrosine phosphorylated carboxy-terminus of the receptor. To gain further insights into the mechanisms and interactions regulating these processes, we have analyzed transfected NIH-3T3 cells expressing two EGF-R carboxy-terminal deletion mutants (CD63 and CD126) with reduced capacity to stimulate PI hydrolysis, Ca2+ rises, and DNA synthesis. In fact, the CD126 mutant lacking 126 carboxy-terminal amino acids, including four tyrosine autophosphorylation sites, was unable to stimulate PI hydrolysis or Ca2+ rise in response to EGF. Surprisingly, EGF binding to the cell lines expressing CD63 or CD126 mutants was followed by similar stimulation of tyrosine phosphorylation of PLC gamma. Our results suggest that although necessary, tyrosine phosphorylation of PLC gamma may not be sufficient for stimulation and PI hydrolysis. It is clear, however, that the carboxy-terminal region of EGF-R is involved in regulation of interactions with cellular targets and therefore plays a crucial role in postreceptor signaling pathways.
Similar articles
-
Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively.Mol Cell Biol. 1993 Jan;13(1):133-43. doi: 10.1128/mcb.13.1.133-143.1993. Mol Cell Biol. 1993. PMID: 7678051 Free PMC article.
-
Effects of substitution of threonine 654 of the epidermal growth factor receptor on epidermal growth factor-mediated activation of phospholipase C.J Biol Chem. 1990 Apr 25;265(12):7009-15. J Biol Chem. 1990. PMID: 2108964
-
Transmembrane signalling at the epidermal growth factor receptor. Positive regulation by the C-terminal phosphotyrosine residues.Biochem J. 1991 Jul 15;277 ( Pt 2)(Pt 2):305-11. doi: 10.1042/bj2770305. Biochem J. 1991. PMID: 1713444 Free PMC article.
-
Epidermal growth factor activates phospholipase C in rat hepatocytes via a different mechanism from that in A431 or rat1hER cells.Mol Pharmacol. 1992 Nov;42(5):743-52. Mol Pharmacol. 1992. PMID: 1435749
-
Cellular proliferation and lipid metabolism: importance of lipoxygenases in modulating epidermal growth factor-dependent mitogenesis.Cancer Metastasis Rev. 1994 Dec;13(3-4):397-410. doi: 10.1007/BF00666106. Cancer Metastasis Rev. 1994. PMID: 7712598 Review.
Cited by
-
GSK-3 inactivation or depletion promotes β-cell replication via down regulation of the CDK inhibitor, p27 (Kip1).Islets. 2011 Jan-Feb;3(1):21-34. doi: 10.4161/isl.3.1.14435. Epub 2011 Jan 1. Islets. 2011. PMID: 21278490 Free PMC article.
-
Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation.Oncogene. 2004 Jul 15;23(32):5523-31. doi: 10.1038/sj.onc.1207712. Oncogene. 2004. PMID: 15107818 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous